Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

241.67
+4.341.83%
Post-market: 241.750.0800+0.03%19:11 EDT
Volume:7.35M
Turnover:1.78B
Market Cap:12.44B
PE:-64.59
High:247.50
Open:239.88
Low:238.25
Close:237.33
52wk High:260.19
52wk Low:96.09
Shares:51.46M
Float Shares:41.87M
Volume Ratio:6.79
T/O Rate:17.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7414
EPS(LYR):-3.6821
ROE:-349.38%
ROA:-16.84%
PB:227.82
PE(LYR):-65.63

Loading ...

Axsome Therapeutics doses first patient in FOCUS-3 trial

TIPRANKS
·
Jun 26

Axsome Doses First Patient in Focus-3 Phase 3 Trial of Solriamfetol for Adolescent ADHD

Reuters
·
Jun 26

Axsome Therapeutics Initiates Focus-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (adhd)

THOMSON REUTERS
·
Jun 26

Definium's LSD-based depression pill delivers strong late-stage results, shares surge

Reuters
·
Jun 22

Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month

GlobeNewswire
·
Jun 18

Axsome Therapeutics price target raised to $300 from $275 at TD Cowen

TIPRANKS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 17

Axsome presents new Phase 3 ENCORE trial data for AXS-12 in narcolepsy with cataplexy at SLEEP 2026

Reuters
·
Jun 15

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

GlobeNewswire
·
Jun 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Axsome adopts executive severance, change-in-control plan effective June 5, 2026

Reuters
·
Jun 10

Axsome Therapeutics shareholders elect Saad, Mahony as Class II directors

Reuters
·
Jun 10

Axsome Therapeutics CEO Herriot Tabuteau disposes of USD 11.97 million in common shares

Reuters
·
Jun 10

Axsome CFO Nick Pizzie sells 33,000 shares for $7.92 million

Reuters
·
Jun 10

What Axsome Therapeutics (AXSM)'s SUNOSI Patent Settlements and Migraine Updates Mean For Shareholders

Simply Wall St.
·
Jun 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 04

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

GlobeNewswire
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 03